392 related articles for article (PubMed ID: 12829139)
21. The genetic epidemiology of second primary breast cancer.
Bernstein JL; Thompson WD; Risch N; Holford TR
Am J Epidemiol; 1992 Oct; 136(8):937-48. PubMed ID: 1456270
[TBL] [Abstract][Full Text] [Related]
22. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma.
Huang J; Walker R; Groome PG; Shelley W; Mackillop WJ
Cancer; 2001 Sep; 92(6):1411-8. PubMed ID: 11745217
[TBL] [Abstract][Full Text] [Related]
23. Rates of second malignancies after definitive local treatment for ductal carcinoma in situ of the breast.
Shaitelman SF; Grills IS; Kestin LL; Ye H; Nandalur S; Huang J; Vicini FA
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1244-51. PubMed ID: 21030159
[TBL] [Abstract][Full Text] [Related]
24. Second malignancy in young early-stage breast cancer patients with modern radiotherapy: A long-term population-based study (A STROBE-compliant study).
Xie L; Lin C; Zhang H; Bao X
Medicine (Baltimore); 2018 Apr; 97(17):e0593. PubMed ID: 29703057
[TBL] [Abstract][Full Text] [Related]
25. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.
Elkin EB; Klem ML; Gonzales AM; Ishill NM; Hodgson D; Ng AK; Marks LB; Weidhaas J; Freedman GM; Miller RC; Constine LS; Myrehaug S; Yahalom J
J Clin Oncol; 2011 Jun; 29(18):2466-73. PubMed ID: 21576642
[TBL] [Abstract][Full Text] [Related]
27. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy.
Boyages J; Recht A; Connolly JL; Schnitt SJ; Gelman R; Kooy H; Love S; Osteen RT; Cady B; Silver B
Radiother Oncol; 1990 Sep; 19(1):29-41. PubMed ID: 2173044
[TBL] [Abstract][Full Text] [Related]
28. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
30. Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.
Zeidan AM; Long JB; Wang R; Hu X; Yu JB; Huntington SF; Abel GA; Mougalian SS; Podoltsev NA; Gore SD; Gross CP; Ma X; Davidoff AJ
PLoS One; 2017; 12(9):e0184747. PubMed ID: 28902882
[TBL] [Abstract][Full Text] [Related]
31. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.
Claus EB; Stowe M; Carter D; Holford T
Breast; 2003 Dec; 12(6):451-6. PubMed ID: 14659121
[TBL] [Abstract][Full Text] [Related]
32. Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.
Brooks JD; John EM; Mellemkjaer L; Lynch CF; Knight JA; Malone KE; Reiner AS; Bernstein L; Liang X; Shore RE; Stovall M; ; Bernstein JL
Cancer Med; 2016 Nov; 5(11):3282-3291. PubMed ID: 27700016
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of radiation therapy in older women with ductal carcinoma in situ.
Smith BD; Haffty BG; Buchholz TA; Smith GL; Galusha DH; Bekelman JE; Gross CP
J Natl Cancer Inst; 2006 Sep; 98(18):1302-10. PubMed ID: 16985249
[TBL] [Abstract][Full Text] [Related]
34. Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer.
Xie L; Bao X; Cai T; Silva SG; Ma J; Zhang Z; Guo X; Marks LB
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):275-284. PubMed ID: 31201893
[TBL] [Abstract][Full Text] [Related]
35. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.
Berrington de Gonzalez A; Curtis RE; Gilbert E; Berg CD; Smith SA; Stovall M; Ron E
Br J Cancer; 2010 Jan; 102(1):220-6. PubMed ID: 19935795
[TBL] [Abstract][Full Text] [Related]
36. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.
Nichols HB; Berrington de González A; Lacey JV; Rosenberg PS; Anderson WF
J Clin Oncol; 2011 Apr; 29(12):1564-9. PubMed ID: 21402610
[TBL] [Abstract][Full Text] [Related]
37. Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer.
Gold HT; Do HT; Dick AW
Cancer; 2008 Dec; 113(11):3108-15. PubMed ID: 18932243
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
[TBL] [Abstract][Full Text] [Related]
39. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer.
Bernstein JL; Thompson WD; Risch N; Holford TR
Am J Epidemiol; 1992 Oct; 136(8):925-36. PubMed ID: 1456269
[TBL] [Abstract][Full Text] [Related]
40. Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.
Prater J; Valeri F; Korol D; Rohrmann S; Dehler S
J Cancer Res Clin Oncol; 2016 Feb; 142(2):365-71. PubMed ID: 26298838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]